Normal Range of Fasting Insulin for Middle-Aged South Asian Postmenopausal Females
For a middle-aged South Asian postmenopausal female, the normal fasting insulin range is approximately 2.6-14.6 µIU/mL (or mIU/L), with a median around 7.7 µIU/mL, based on the most recent population-specific data from South Asian populations.
Evidence-Based Reference Ranges
The most relevant and recent evidence comes from a 2026 study establishing reference intervals specifically in a South Asian population from Nepal 1. This study provides:
- Fasting insulin: 2.63-14.56 µIU/mL (median 7.69 µIU/mL)
- HOMA-IR: 0.56-3.50 (for insulin resistance assessment)
- HOMA-%S: 58.83-233.20 (for insulin sensitivity)
This represents the first population-specific reference intervals for South Asians and is directly applicable to your patient population.
Important Population-Specific Considerations
South Asian populations demonstrate distinct insulin physiology compared to Western populations:
- South Asians typically have higher fasting insulin levels and greater insulin resistance at similar BMI levels compared to white populations 2
- They show an inadequate pancreatic beta-cell reserve, with steeper age-related increases in fasting glucose 2
- Post-load insulin levels are consistently higher in South Asians (by approximately 0.7 log pmol/L) 2
Age and Menopausal Status Impact
For middle-aged individuals, fasting insulin shows a decreasing trend with age in both genders 3. However, South Asian women specifically demonstrate:
- Higher baseline insulin levels compared to white populations
- Progressive decline in insulin sensitivity with age (HOMA2-%S)
- Less robust age-related increase in beta-cell function (HOMA2-%B) compared to white individuals 2
Clinical Interpretation Thresholds
For identifying insulin resistance or metabolic dysfunction:
- Fasting insulin ≥10 mIU/L suggests insulin resistance in women 4, 5
- HOMA-IR ≥2.0 indicates insulin resistance in women 5
- Values above these thresholds warrant evaluation for metabolic syndrome, even with only 1-2 metabolic criteria present
Comparative Reference Values from Other Studies
Supporting data from Iranian adults (similar ethnic background) shows 3:
- Women: 2.34-11.98 µIU/mL (95% reference interval)
- HOMA-IR: 0.40-1.80
- QUICKI: 0.33-0.42
Korean population data provides additional context 6:
- Median fasting insulin: 7.69 µIU/mL
- 75th percentile: 9.82 µIU/mL
- Metabolic syndrome risk threshold: 9.7 µIU/mL
Critical Caveats
These reference ranges assume:
- Normal BMI (18.5-24.9 kg/m²)
- No renal or hepatic insufficiency
- No medications affecting insulin sensitivity
- Fasting state (8-12 hours)
- Standardized assay methods (chemiluminescence immunoassay preferred)
Laboratory method matters: The thresholds were validated using specific immunometric assays (IRMA or ICMA methods) 7. Your laboratory should validate these ranges with their specific assay platform.
Practical Application
For your middle-aged South Asian postmenopausal patient:
- Normal range: 2.6-14.6 µIU/mL
- Optimal target: <10 µIU/mL to minimize metabolic risk
- Concerning if: ≥10 µIU/mL (suggests insulin resistance)
- Highly abnormal if: >14.6 µIU/mL (above 97.5th percentile)
Consider concurrent assessment of:
- Fasting glucose (should be <5.3 mmol/L or <95 mg/dL)
- HOMA-IR calculation (normal <2.0 for women)
- Waist circumference and blood pressure (biological determinants of insulin levels) 3
The use of population-specific reference ranges is essential because Western-derived values systematically underestimate insulin resistance risk in South Asian populations, potentially delaying intervention for metabolic syndrome and type 2 diabetes prevention.